Instant
Quantification

of genetic modifications for Cell and Gene Therapies

With QUiCKR, file IND 10 months sooner and save 30%
Lead Optimization
360 Days
70 Days
Testing Cost
$500,000
$350,000
Faster to market, earlier therapy sales
+30%

QUiCKR V2

20 min sample-to-results

High-Throughput
Automated
0 new instruments required

30,000+ reactions analyzed to date

QUiCKR Workflow

Quantification Using initial CRISPR Kinetic Rates

Edited Sample

Sample Prep

Plate Transfer

Fluorescent
Readout

Cloud-based
Instant Results

Meet Our Team

We are passionate about accelerating broad access to life saving genetic medicines. Our mission is to engineer tools that test genetic modifications instantaneously. Imagine a world where genetic engineering can iterate as fast as software engineering.

Charles Blanluet
CEO & Cofounder
Stanford Microfludics,
Guardant
Prof. Juan Santiago
Scientific Cofounder
Stanford Microfludics, Purigen Biosystems
Jiawei Lee
CBO & Cofounder
UC Berkeley & UCSF, Sequoia
Henrik Sperber
CTO & Cofounder
CRISPR Therapeutics, Paratus Sciences
Prof. Matthew Porteus
Scientific Advisor
Stanford Medicine, CRISPR Therapeutics